Serum ANGPTL8 levels were significantly higher (p <0.001) in NAFLD patients (1095.0 ± 541.3 pg/mL) compared to controls (730.0 ± 431.1 pg/mL). Here, ANGPTL8 is linked to metabolic dysfunction-associated steatotic liver disease.